GL1X · GenesisL1 explorer

MolNFT v1 · #32934 · protein

A comparative study of uracil DNA glycosylases from human and herpes simplex virus type 1

2C53: “A comparative study of uracil DNA glycosylases from human and herpes simplex virus type 1”. X-ray diffraction, 1 ligand (DUR), 1 pocket (best druggability 0.58). MolNFT v1 #32934 on GenesisL1: 3D structure, binding sites and pockets…

PDB
2C53
Type
protein
Length
228 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Uracil DNA glycosylase
EC
3.2.2.3
UniProt
P10186
Ligands
DUR
Pockets
1 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 42% helix, 11% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUracil DNA glycosylase (EC 3.2.2.3)protein22842% helix, 11% strandP10186

Ligands and binding sites

  • DUR · 2'-deoxyuridine · ligand · chains A
  • GOL · Glycerol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11990.580.8033DUR

Compared structures

  • 2C53 · A comparative study of uracil DNA glycosylases from human and herpes simplex virus type 1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.